Catalyst Wire Dossier Catalyst Wire Dossier

nMARQ Pulmonary Vein Isolation System

· Biosense Webster, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for nMARQ Pulmonary Vein Isolation System, covering 2018-12-12 to 2018-12-12. Get the full timeline:

Most recent: Clinical Trial Update: nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation [Phase 3]

See pricing